Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Carduus marianus
Chardon européen utilisé pour les amers digestifs et le soutien hépatique ; propriétés galactogènes.
Carduus marianus (milk thistle) is a European thistle traditionally used as a digestive bitter and liver support herb. Its primary active compounds include silymarin (a complex of flavonolignans), cnicin, and polyacetylenes, which contribute to hepatoprotective, anti-inflammatory, and galactagogue effects. Modern evidence, though limited, supports its use for liver conditions and lactation enhancement.
Silymarin, particularly silybin, exerts hepatoprotective effects through antioxidant activity, inhibition of lipid peroxidation, and modulation of nuclear factor kappa B (NF-κB) signaling, reducing hepatic inflammation. It also stimulates protein synthesis in hepatocytes and may inhibit the binding of toxins to liver cell membranes. Cnicin activates bitter taste receptors (TAS2Rs) on the tongue and in the gastrointestinal tract, promoting digestive secretions and biliary flow. The galactagogue effect is thought to involve increased prolactin secretion, though the precise mechanism remains unclear.
Chardon européen utilisé pour les amers digestifs et le soutien hépatique ; propriétés galactogènes.
Carduus marianus (milk thistle) is a European thistle traditionally used as a digestive bitter and liver support herb. Its primary active compounds include silymarin (a complex of flavonolignans), cnicin, and polyacetylenes, which contribute to hepatoprotective, anti-inflammatory, and galactagogue effects. Modern evidence, though limited, supports its use for liver conditions and lactation enhancement.
Silymarin, particularly silybin, exerts hepatoprotective effects through antioxidant activity, inhibition of lipid peroxidation, and modulation of nuclear factor kappa B (NF-κB) signaling, reducing hepatic inflammation. It also stimulates protein synthesis in hepatocytes and may inhibit the binding of toxins to liver cell membranes. Cnicin activates bitter taste receptors (TAS2Rs) on the tongue and in the gastrointestinal tract, promoting digestive secretions and biliary flow. The galactagogue effect is thought to involve increased prolactin secretion, though the precise mechanism remains unclear.